Deepak Sapra is a distinguished business leader, author, and social entrepreneur, currently CEO of PSAI at Dr. Reddy’s Laboratories and board member at APSL (a subsidiary of Dr. Reddy’s Laboratories). An IIM Bangalore and IRIMEE alumnus. He has also been awarded prestigious international fellowships, including the Chevening Scholarship (UK) and the Fulbright Fellowship (USA). He co-founded Priyajan, driving inclusive development in rural India. Through his diverse portfolio of leadership, writing, and community initiatives, he continues to shape both the business and human sides of healthcare and public service.

Amit Parekh serves as Vice President & Head – PSAI (API & APSL), API Finance at Dr. Reddy’s Laboratories. Amit balances business growth with strong governance, believing finance is both a growth enabler and the organization’s last line of defence. He is passionate about driving results through business partnering, financial planning, reporting, M&A, and strategic decision-making.

Azhar is a seasoned leader with over 18 years of experience in business building, digital transformation, strategy, and product leadership. In his current role as the Global Head of Digital & Technology (PSAI) at Dr. Reddy's Laboratories, he leads the customer success and business growth for the region, as well as builds a digital platform business and leads digital transformation and technology initiatives across the organization. 

B. Vivek is Executive Vice President and Global Head of Supply, Demand Planning & Delivery at Dr. Reddy’s Laboratories. He plays a pivotal role in ensuring end-to-end supply continuity, customer satisfaction, and operational resilience across global markets. In his additional capacity as Vice President and Global Delivery Head for Project Management (API & Formulations), Vivek leads cross-functional teams that drive innovation, efficiency, and speed-to-market for strategic partnerships and CDMO engagements.

Dr. A. Kalyan Chakravarthy is a seasoned pharmaceutical leader with over two decades of experience in drug development, formulation innovation & regulatory affairs. He currently serves as Executive Vice President and Head – SEMEA and B2B Formulations. His tenure in the pharmaceutical industry reflects a deep understanding of technical, operational, and regulatory complexities spanning both emerging and developed markets.

No bio available.

Dr. Rajeev Rehani Budhdev currently serves as the Executive Vice President and Head of API R&D at Dr. Reddy’s Laboratories. Renowned for championing novel technologies, including continuous manufacturing and flow chemistry, he brings strategic vision to every stage of API innovation.

E. Sreedhar is the Executive Vice President and Head of API Regulatory Affairs, with over 30 years of experience in pharmaceutical regulatory strategy, he oversees global regulatory affairs of Dr. Reddy’s, ensuring compliance with international regulatory agencies. His collaborative leadership, commitment to documentation excellence, and focus on patient-centric compliance have made him a key force behind Dr. Reddy’s reputation as a trusted global API supplier.

A seasoned pharmaceutical leader with over two decades of industry experience, including 17 years leading international operations across Latin America and Mexico. As Vice President of API Sales & Marketing, he has consistently delivered growth through strategic P&L management, start-up operations, and expansive sales, marketing, technical, and business development leadership.

Kalpesh leads strategic growth across regulated markets, focusing on building global pharma partnerships that enable patient access, innovation, and sustainable supply chains. With over 20 years of experience across Europe, CIS, Israel, and Asia-Pacific, Kalpesh specializes in expanding API/CDMO business across geographies and therapeutic areas, driving complex licensing and out-licensing deals, leading cross-functional commercial teams across emerging and developed markets, & Delivering P&L performance and long-term strategic collaborations.

Karun Gaur is an accomplished pharmaceutical industry leader with decades of global experience spanning API marketing, regional business leadership, and strategic healthcare alliances. Currently serving as Vice President & Head of Strategic Alliances & Access at Dr. Reddy’s Laboratories, Karun drives initiatives to expand access to quality healthcare across emerging markets through technology transfer, local manufacturing support, and collaborative partnerships.

No bio available.

With nearly 28 years at Dr. Reddy’s Laboratories, Nirav Shah is a powerhouse of strategic leadership and commercial excellence in the global pharmaceutical industry. Currently serving as Vice President – North Asia, Nirav drives market growth and profitability across API, formulations, and biosimilars by building resilient business ecosystems and nurturing high-impact customer relationships. 

No bio available.

Seasoned Human Resources leader with a career spanning over 15 years across various roles in the pharmaceutical industry. Championed forward-thinking HR practices that have helped redefine the organisation’s talent landscape. Worked across roles in business HR, driving performance. Led organisation-wide transformation interventions in the space of organisation effectiveness, employee experience, and talent management.